COMMUNICATION
1989; Wiley; Volume: 96; Issue: S1 Linguagem: Inglês
10.1111/j.1476-5381.1989.tb16582.x
ISSN1476-5381
Tópico(s)Receptor Mechanisms and Signaling
ResumoBritish Journal of PharmacologyVolume 96, Issue S1 p. 1P-368P Free Access COMMUNICATION First published: March 1989 https://doi.org/10.1111/j.1476-5381.1989.tb16582.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Cheetham, S.C. et al. (1988) Brain Res. 443, 272– 280. Crow, T.J. et al. (1984) Neuropharmacology 23, 1561– 1569. McKeith, I.G. et al. (1987) J. Affect. Disord. 13, 67– 74. Owen, F. et al. (1986) Brain Res. 362, 185– 188. Brazell, M.P. et al. (1985) Br. J. Pharmacol. 86, 209– 216. Ceulemans, D.L.S. et al. (1985) Psychopharmacol. 85, 329– 332. Leysen, E. et al. (1986) Psychopharmacol. 88, 434– 444. Reyntjens, A. et al. (1986) Drug Dev. Res. 8, 205– 211. Sharp, T. et al. (1988) Br. J. Pharmacol. 93, 94P. Aulakh C.S. et al (1988) Eur J Pharmacol 146, 253– 259. Goodwin G.M. et al (1985) Neuropharmacol 24, 1187– 1194. Traber J. and Glaser T. (1987) TIPS 8, 432– 437. Bendotti, C. and Samanin, R. (1986) Eur. J. Pharmacol. 121 147– 150. Hoyer, D. (1988) J. Receptor Res. 8 59– 81. Hutson, P.H. et al (1986) Eur. J. Pharmacol. 129 347– 352. Hutson, P.H. et al (1988) Eur. J. Pharmacol. 150 361– 366. Galzin A.M., Moret C., Verzier B., Langer S.Z. J. Pharmac. Exp. Ther. 235, 200– 211, 1985. Langer S.Z., Moret C. J.Pharmac. Exp. Ther. 222, 220– 226, 1982. Moret C., Briley M. Neuropharmac. 27, 43– 49, 1988. Fuller, R.W., Snoddy, H.D. and Molloy, B.B. (1986). J. Pharmac. Exp. Ther. 239, 454– 459. Hjorth, S. and Carlsson, A. (1983). Eur. J. Pharmac. 83, 299– 303. Yocca, F.D. et al (1987). Eur. J. Pharmac. 137, 293– 294. Barnes NM et al (1988). Br. J. Pharmacol., 94, 319P. Hoyer D. and Neijt HC (1987). Eur. J. Pharmacol., 143, 191– 192. Hoyer D. and Neijt HC (1988). Mol. Pharmacol., 33, 303– 309. Kilpatrick GJ et al, (1987). Nature, 330, 746– 748. Neijt HC et al (1988). Naunyn Schmiedeberg's Arch. Pharmacol., 337, 491– 499. Peroutka SJ and Hamik A. (1988). Eur. J. Pharmacol., 148, 297– 299. Waeber C. et al (1988). Eur. J. Pharmacol., 151, 351– 352. Watling KJ et al (1988). Eur. J. Pharmacol., 149, 397– 398. Barnes, N.M. et al. (1988) Br. J. Pharmacol. 94, 391P. Kilpatrick, G.J. et al. (1987) Nature 330, 746– 748. Peroutka, S.J. & Hamik, A. (1988) Eur. J. Pharmacol. 148, 297– 299. Watling, K.T. et al. (1988) Eur. J. Pharmacol. 149, 397– 398. Bouhelal R. et al, (1988), Eur J Pharmacol, 151, 189– 196. Hoyer D., (1988a), TIPS, 9, 89– 94. Hoyer D., (1988b), J Rec Research, 8, 59– 81. Kennett GA and Curzon G., (1988), Br J Pharmacol, 94, 137– 147. Neale RF et al, (1987), Eur J Pharmacol, 136, 1– 9. Schoeffter P. and Hoyer D., (1988), Br J Pharmacol. in press. Schoeffter P. et al, (1988), Naunyn Schmiedeberg's Arch Pharmacol, 337, 602– 608. Sills MA et al, (1984), J Pharmacol Exp Ther, 231, 480– 487. Conn, P.J. & Sanders-Bush, E. (1986). J. Neurosci. 6, 3669– 3675. Costall, B. et al (1986) Neuropharmacology 14, 859– 868. Kavaliers M. & Innes D. (1988) Physiol. Behav. 42; 131– 135. Rodgers R.J. & Randall J.I. (1986a) Physiol. Behav. 36; 947– 950. Rodgers R.J. & Randall J.I. (1986b) Physiol. Behav. 37; 317– 322. Rodgers R.J. & Randall J.I. (1987) Psychopharmacology 91; 305– 315. Traber J. & Glaser T. (1987) TIPS 8; 432– 437. Costall B. et al. (1986) Neuropharmacology 25, 959– 961. Costall B. et al. (1988) Br. J. Pharmac., in press. Dixon A.K. (1982) Triangle 21, 95– 105. Jones B.J. et al. (1987) Br. J. Pharmac. 90, 88p. Williams F. M. et al. (1985) J. Cardiovasc. Pharmac. 7, 550– 555. Rich, D.A., Parker, V., Cariuk, P., Morinan, A. & Horton, R.W. (1988) Br.J. Pharmac. 93 179P. Stanford, S.C., Parker, V. & Morinan, A. (1988) J.Affect.Dis. in press. Huang, M., Messing, R.B. & Sparber, S.B. (1987) Life Sci. 41, 1083– 1088. Sara, S.J. & De Vauges V. (1986) Psychopharmacol. 89, Suppl. S31. Robbins, T.W. (1984) Psychol. Med. 14, 13– 21. Roberts, D.C.S. (1981) in Theory in Psychopharmacology-1′ S.J. Cooper (ed), pp 123– 148. Academic. Dourish C.T. et al (1988a) Eur. J. Pharmacol., in press. Dourish C.T. et al (1988b) Soc. Neurosci. Abstr., in press. Rodgers R.J. & Randall J.I. (1985) Pharmacol. Biochem. Behav. 23: 883– 888. Watkins L.R. & Mayer D.J. (1986) Ann. NY Acad. Sci. 467; 273– 299. Davies, C., Stanford, C., Steinberg, H. & Sykes, E.A. (1986) Br. J. Pharmac. 89, Proc. Suppl., 531P. Davies, C., Stanford, C., Steinberg, H., Sykes, E.A. & Terry, P. (1988) Pharmacopsychiat. 21, 59 (8). Kennett, G.A., Dourish, C.T. & Curzon, G. (1987) Europ. J. Pharmac. 134, 265– 274. Holmer, E. et al. (1982) Thromb. Res., 25, 475– 485. Bara, L. et al. (1986) Nouv. Rev. Fr. Hematol, 28, 355– 358. Hennekes, R. et al. (1988) Invest. Ophthalmol. Vis. Sci. 29, (Suppl.) 82. Lee, P.-Y. et al. (1985) Curr. Eye Res. 4, 775– 781. Sugrue, M.F. et al. (1985) J. Pharmacol. Exp. Ther. 232, 534– 540. Sugrue, M.F. et al. (1988) Invest. Ophthalmol. Vis. Sci. 29 (Suppl.) 81. R. Trouve, G. Nahas, M. Sitbon, C. Latour, (1987), J.Am.Coll.Tox., 6: 559– 560. G. Nahas, R. Trouve, J.F. Demus, M. Sitbon, C. Latour, (1987), J.Am.Coll.Tox., 6: 560. D.E. Davidson et al. (1980) In: ‘Radiation sensitizers: Their use in the chemical management of cancer’ pp 309– 320. Academic Press, New York. D. Glover et al. (1986) Int. J. Radiat. Oncol. Biol. Phys. 12 1509– 1512. N.F. Swynnerton et al. (1986a) Int. J. Radiat. Oncol. Biol. Phys. 12 1495– 1498. N.F. Swynnerton et al. (1986b) Res. Comm. Chem. Path. Pharm. 54 255– 269. A.T. Turrisi et al. (1986) Cancer Treat. Rep. 70 1389– 1393. Johnson, L.N., Acharya, K.R. & Stuart, D.I., (personal communication) Goodford, P.J. (1985) J. Med. Chem. 28, 849. Hu, H-Y. & Gold, A.M. (1975) Biochem. 14, 2224. Kasvinsky, P.J., Madsen, N.B., Sygusch, J. & Fletterick, R.J. (1978) J. Biol. Chem. 253, 3343. Merida, I., Menendez, M. & Laynez, J. (1984) Int. J. Biol. Macromol. 6, 58. Newgard, C.B., Nakano, K., Hwang, P.K. & Fletterick, R.J. (1986) Proc. Nat. Acad. Sci. 83, 8132. Lacassagne A. (1936) Am. J. Cancer 14, 217– 228. Jordan, V.C. (1984) Pharm. Rev. 36, 245– 276. Jordan, V.C. (1988) Breast Cancer Res. Treat. 11, 197– 209. Orme, M.L., Lewis, P.J., Serlin, M.J., et al. Br. Med. J. 1, 1564– 1565, 1977. McBurney, J.J., Meier, T.J. & Hoag, W.G., J. Lab. Clin. Med. 64, 485– 487, 1964. Shearer, M.J. (1986) in “Methods in Enzymology”. Vol.123 (14). Vitamins and Co-enzymes, pp 223– 234. Orlando, Academic Press. Connelly, D.M. & Taberner, P.V. (1986) Br.J.Pharmac. 87, 120P. Connelly, D.M. et al (1987) Alcohol Alcoholism Suppl. 1, 301– 305. Unwin, J.W. & Taberner, P.V. (1980) Neuropharmacology 19, 1257– 1259. Harris, J.B. (1984) Prog.Med.Chem. 21, 63– 110. Harris, J.B. & Johnson, M.A. (1978) Clin.Exp.Pharm.Phys. 5, 587– 600. Hood, V.L. & Johnson, J.R. (1975) Med.J.Aust. 2, 638– 641. Bacon, K.B. et al. (1988) Br. J. Pharmacol. 95, 966– 974. Bos, J.D. et al. (1987) J. Invest. Dermatol. 88, 569– 573. Brain, S.D. et al. (1984) J. Invest. Dermatol. 83, 70– 73. Smolle, J. et al. (1985) Acta Derm. Venereol. 65, 479– 483. Weir, S.W. & Weston, A.H. (1986) Br. J. Pharmacol., 88, 113– 120. Bicknell R.J. & Leng G. (1982) Nature (Lond) 298, 161– 162. North R.A. (1986) TINS 10, 114– 117. Racké K., Altes U., Baur A.M., Jost D. & Schäfer J. (1987) Brain Res. 436, 371– 373. Foster, C.D. & Brading, A.F. (1987). Proceedings of Xth IUPHAR Congress, Sydney, P1002. Lindnér, P., Mattiasson, A., Persson, L. & Uvelius, B. (1988). J. Urol. In press. Olsen et al. (1985) Am. J. Physiol. 249, F299– F307. Bowmer, C.J. et al., (1986). Br. J. Pharmac., 88, 205– 212. Haleen, S.J. et al., (1987). Life Sci., 40, 555– 561. Gordon, E.M. et al., (1986) Biochem. Soc. Trans. 15, 457– 458. Gordon, E.M. et al., (1987) in ‘Nephrotoxicity: Extrapolation from in vivo to IN VITRO and from animals to man’. Eds Bach & Lock, Plenum Press (in press). Lapkin, R. et al., (1977) J. Pharm. Exp. Ther. 201, 233– 242. Marche, P. (1987) Kid. Int. 31, 59– 64. Dowd, P.M. et al (1988) Skin Pharmacology 1, 30– 37. Fincham, N.J. et al (1988) J.Immunol. 140, 4294– 4299. Gahring et al (1985) J.Clin.Invest. 76, 1585– 1591. Gearing, A.J.H. et al, (1987) J.Immunol.Methods 99, 7– 13. Esplugues, J.V. & Whittle, B.J.R. (1988). Br. J. Pharmac., 93, 222– 228. Yanagisawa, M., Kurihara, H. et al. (1988). Nature, 332, 411– 415. Whittle, B.J.R. (1983) Br. J. Pharmac., 80, 545– 551. Whittle, B.J.R. & Esplugues, J.V. (1988). Br. J. Pharmac. (In press). Esplugues, J.V. & Whittle, B.J.R. (1988a) Br. J. Pharmac., 93, 222– 228. Esplugues, J.V. & Whittle, B.J.R. (1988b) J. Physiol., 398, 99P. Smith T.W., Buchan P., Parsons, D.N. & Wilkinson, S. (1982). Life Science, 31, 1205– 1208. Masters, D.J., Jacobs, V.N., Carr, V.J. and McMillan, R.M. (1988). Biochem. Soc. Trans. 16, 38. McMillan, R.M., Millest, A.J., Proudman, K.E. and Taylor, K.B. (1986). Br.J.Pharmacol. 87, 53P. Aked, D., Foster, S.J., Howarth, A. & Potts, H.C. (1986) Br.J.Pharmac. 89, 431. Aked, D. & Foster, S.J. (1987) Br.J.Pharmac. 92, 545. Rampart, M.R. & William, T.J. (1988) Br.J.Pharmac. 94, 1143. Boughton-Smith, N.K. & Whittle, B.J.R. (1988) Prostaglandins 35, 945– 957. Peskar, B.M., et al (1986) Prostaglandins 31, 283– 293. Rainsford, K.D. (1987) Agents & actions 21, 316– 319. Wedmore, C.V. and Williams, T.J. (1981) 289, 646– 650. Wood, B.E. et al Br. J. Pharmac. (1988) 94, 416p. Anderson, D.C. & Springer, T.A. (1987). Ann.Rev.Med., 38, 175– 194. Becker, E.L. et al. (1986). Fed.Proc., 45, 2151– 2155. Rampart, M. & Williams, T.J. (1988). Br.J.Pharmac., 94, 1143– 1148. Wallis, W.J. et al. (1986). Blood, 67, 1007– 1013. Baker, A.J. & Fuller, R.W. (1988) Br. J. Pharmac. in press. Persson, C.G.A. (1986) Lancet ii, 1126– 1129. Camp, R.D.R. et al (1986). J. Immunol. 137, 3469– 3474. Cavender, D.E. et al (1986). J. Immunol. 136, 203– 208. Cavender D.E. et al (1987). J. Immunol. 139, 1855– 1860. Fowler, C.J. & Ross, S.B. (1984) Med. Res. Rev. 4, 323– 358. Arai, R., Kimura, H. & Maeda, T. (1986) Neurosci. 19, 905– 925. Westlund, K.N., Denney, R.M., Rose, R.M. & Abell, C.W. (1988) Neurosci. 25, 439– 456. Da Prada, M., Kettler, R., Keller, H.H., Bonetti, E.P. & Imhof, R. (1986) Adv. Neurol. 45, 175– 178. Da Prada, M., Kettler, R., Keller, H.H., Kyburz, E. & Burkard, W.P. (1987) Pharmacol. Toxicol. 60 (Suppl. 1), 10. Cesura, A.M., Galva, M.D., Imhof, R. & Da Prada, M. (1987) J. Neurochem. 48, 170– 176. Bach, A.W.J., Lan, N.C., Hohnson, D.L., Abell, C.W., Bembenek, M.E., Kwan, S.-W., Seeburg, P.H. & Shih, J.C. (1988) Proc. Natl. Acad. Sci. USA 85, 4934– 4938. Baron K.D., Dentinger M.P. et al. (1988) Acta Neuropathol (Berl) 75: 295– 307. Bowery N.G., Hill D.R. & Hudson A.L. (1983) Br.J.Pharmac. 78: 191– 206. Garay R.P. et al. (1986) Naunyn-Schmiedebergs Arch Pharmacol 334: 202– 209. Wilkin G.P., Hudson A.L., Hill D.R. & Bowery N.G. (1981) Nature 294: 584– 587. Metcalf, G. (1982) Brain Res. Rev. 4, 389– 408. Sharif, N.A. and Burt, D.R. (1983) Regul. Peptides, 7, 399– 411. Szirtes, T., et al. (1984) J. Mad. Chem. 27, 741. Brown, R.G. & Marsden, C.D. (1984) Lancet ii, 1262– 1265. Mash, D.C., Flynn, D.D. & Potter, L.T. (1985) Science 228, 1115– 1117. Ruberg, M., Ploska, A., Javoy-Agid, F. & Agid, Y. (1982) Brain Res. 232, 129– 139. Freeman J.J. et al (1979) J. Pharmac. Exp. Ther. 210: 91– 97. Gardiner J.E. (1961) J. Biochem. 81: 297– 234. Salamone J.D. (1984) Behav. Brain Res. 13: 63– 70. Kleinrok, A. & Kilbinger, H. (1983) Naunyn-Schmiedeberg's Arch Pharmacol 322: 216– 220. Bowery, N.G. (1982) Trends in Pharmacological Sciences 3: 400– 403. Dingwall, J.G., Ehrenfreund, J., Hall, R.G. & Jack, J. (1987) United States Patent No. 4, 656– 298. Gillespie, J.S., Maclaren, A., and Pollock, D. (1970) Br J Pharmacol 40, 257– 267. Mas, M., Zahradnik, M.A., Martino, V., and Davidson, M. (1985) Brain Res 342, 128– 134. Bradley PB et al (1986) Neuropharmacology 25 563– 576. Buchheit KH et al (1985) N-S Arch Pharmac 329 36– 41. Butler A., Hill JM, Ireland SJ, Jordan CC, Tyers MB (1988) Br J Pharmac 94 397– 412. Fozard & Kilbinger H. (1985) Br J Pharmac 86 601P. Fosbraey P., Featherstone RL., Morton IKM (1984) N-S Arch Pharmac 326 111– 115. Gunning SJ & Humphrey PPA (1987) Br J Pharmac 91 359P. Sanger GL (1987) J Pharm Pharmac 39 449– 453. Bewley, J.S. & Chapman, I.D. (1988). Br. J. Pharmacol., 93, 52P. Boyle, J.P., Duty, S., Elliott, K.R.F., Foster, R.W., Small, R.C. & Watt, A.J. (1988). This meeting. Paton, D.M. (1981). J. Auton. Pharmacol., 1, 287– 290. Gibson, A. (1988) Br. J. Pharmacol. 92, Proc. Suppl. 26P. Gibson, A., Mirzazadeh, S. & Tucker, J.F. (1988) B.P.S. Dublin, July 1988. Waldman, S.A. & Murad, F. (1987) Pharmac. Rev. 39, 163– 196. Pelckmans, P.A. et al. (1987) Digest. Dis. Sci. 32, No 8, p 923. References Brain, S.D. et al. (1985) Nature 131, 54– 56. Salomon, Y. et al. (1974) Anal. Biochem. 58, 541. Greenberg, B. et al. (1987) Br. J. Pharmac. 92, 789– 794. Rapoport, R.M. & Murad, F. (1983) Circ. Res. 52, 351– 357. Wardlaw, AJ et al. (1986) J.Clin.Invest. 78, 1701– 1706. Kimani, G. et al. (1988) J.Immunol. 140, 3161– 3166. Bruynzeel, P.L.B. et al. (1987) Prostaglandins 34, 205– 214. Kroegel, C. et al. (1988) Immunol. 64, 559– 562. Schwartzman, M.L., Balazy, M., Masferrer, J., Abraham, N.G., McGiff, J.C. and Murphy, R.C.: 12(R)-hydroxyicosatetraenoic acid: a cytochrome P450-dependent arachidonate metabolite that inhibits Na+, K+ -ATPase in the cornea. Proc. Natl. Acad. Sci. 84: 8125– 8129, 1987. Schwartzman, M., Ferreri, N.R., Carroll, M.A., Songu-Mize, E. and McGiff, J.C.: Renal cytochrome P450-related arachidonate metabolite inhibits Na+-K+-ATPase. Nature 314: 620– 622, 1985. Masferrer, J. and Mullane, K.: 12R-hydroxyeicosatetraenoic acid inhibits Na+, K+ -ATPase and attenuates potassium-induced relaxations of rabbit aortae. Circulation 76: Supp. IV: 211, 1987. Quilley, J., McGiff, J.C., Nasjletti, A. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat. Br. J. Pharmacol. Berti, F. et al. (1986) Pharmacol. Res. Commun. 18: 775– 793. Lagente, V. et al. (1987) Prostaglandins. 33: 265– 274. Pretolani, M. et al. (1987) Eur. J. Pharmacol. 140: 311– 321. Pretolani, M. et al. (1988) Am. Rev. respir. Dis., in press. Pretolani, M. et al. Submitted. Ehrenpreis, S. et al (1973). Nature, New Biol, 245, 280– 282. Gintzler, A.R. and Musacchio, J.M. (1975). J. Pharmacol. exp Ther. 194, 575– 585. Murayama, T. and Ui, M. (1983). J. Biol. Chem 258, 3319– 3326. Northup, J.K. (1985). Mol. Aspects Cell. Regul. 4, 91– 116. Poll, C., et al (1988). Br. J. Pharmac., 94: 332P. Shimizu, M., et al (1982). Japan. J. Pharmacol. 32, 47P. Tucker, J.F. and Von Uexkull, A. (1985). Br. J. Pharmac., 86: 579P. Williams, M. et al. Naunyn-Schmiedeberg Arch. Pharmacol., (1986) 332, 179– 183. Banerjee, A.K. et al (1985) Br.J.Pharmac. 84, 71. Coleman, R.A. et al (1987a) Adv.Prost. Thromboxane Leukotriene Res. 17, 467. Coleman, R.A. et al (1987b) Br.J.Pharmac. 91, 407P. Dong, Y.J. et al (1986) Br.J.Pharmac. 87, 97. Kennedy, I. et al (1982) Prostaglandins, 24, 667. Chang et al. (1986). J. Immunol. 136: 1283– 1287. Clark et al. (1986). J. Biol. Chem. 261: 10713– 10718. O'Neill et al. (1987). FEBS Lett. 212: 35– 39. Smith et al. (1987). Biochem. Pharmacol. 36: 3851– 3858. Vane, J.R. (1957). Br. J. Pharmacol. 12: 344– 349. Cross S.E. et al. (1988) Br. J. Pharmacol. (in press). Kennedy et al. (1984) Prostaglandins 24, 667– 689. Schneider, L.H. (1986) J. Hand Surgery 11A, 23– 37. Lumley, P. et al. (1987) Thromb. Haemostas. 58, 261. Alheid, U., Dudel, C. & Forstermann, U. (1987) Br. J. Pharmac. 92, 237– 240. Burton, G.A., Haylor, J.L. & De Jonge, A. (1988) Br. J. Pharmac. Proceedings, BPS Nottingham Meeting. Griffith, T.M., Edwards, D.H., Lewis, M.J. & Henderson, A.H. (1985) Eu. J. Pharmacol. 112. 195– 202. Cynk, E. et al. (1988). J. Physiol. (Abst. Cambridge Meeting). McCall, T. et al. (1988). Br. J. Pharmac. (BPS Meeting, Dublin). Palmer, R.M.J., Ferrige, A.G. & Moncada, S. (1987). Nature, 327, 524– 526. Palmer, R.M.J., Ashton, D.S. & Moncada, S. (1988a). Nature, 333, 664– 666. Palmer, R.M.J. et al. (1988b). Biochem. Biophys. Res. Comm., 153, 1251– 1256. Radomski, M.W. et al. (1987). Br. J. Pharmac., 92, 639– 646. Rimele, T.J. et al. (1988). J. Pharm. Exp. Ther. 245, 102– 111. Lumley, P. et al (1987) Thromb Haemostas., 58, 261. Hawker, R.J. et al (1980). Clin. Sci., 58, 243. Baumgartner H.R. (1973) Microvasc. Res., 5, 167. Krishnamurthi, S. et al. (1986) Biochem. J. 238, 193– 199. Poll, C. et al. (1986) Biochim. Biophys. Res. Commun. 136, 381– 389. Poll, C. et al. (1987) Thrombos. Haemostas. 58, 1676. Tamaoki, T. et al. (1986) Biochim. Biophys. Res. Commun. 135 397– 402. Ahluwalia, A. et al., (1988). Br. J. Pharmac. In press. Coleman, R.A. (1987). In: C. Benedetto et al. (Eds) Prostaglandins and related substances, a practical approach. IRL Press, Oxford, 267– 303. Coleman, R.A. et al. (1980). Br. J. Pharmac. 68, 114P– 115P. Coleman. R.A. et al. (1988). Br. J. Pharmac. In press. Kumlin, M. et al. (1987) in “Advances in Prostaglandin, Thromboxane & Leukotriene Research” Vol 17B, pp 1018– 1022. Raven Press, New York. Samhoun, M.N & Piper, P.J. (1984) Prostaglandins, Leukotrienes & Medicine, 13, 79– 87. Pretolani M., et al. Am. Rev. respir. Dis., 1988, in press. Mazzoni, L. et al. (1985) Br. J. Pharmac. 365, 107P. Page, C.P. et al. (1982) Thromb. Haemost. 47, 210– 213. Kristersson, A. et al. (1988) Br. J. Pharmac. 93, 53P. Sanjar, S. et al. This meeting. Gresele, P. et al. (1986) Biochem. and Biophys. Res. Commun. 137, (1), 334– 342. Wang, S.R. et al (1986) J. Allergy Clin. Immunol. 77, 465– 471. M.A. Boukili, M. Bureau, V. Lagente, J. Lefort, A. Lellouch-Tubiana, E. Malanchère & B.B. Vargaftig. (1986) Br. J. Pharmac. 89, 349– 359. Douglas, J.S., Ridgway, P. & Brink, C. (1977) J. Pharmacol. Exp. Ther. 202, 116– 124. Vincenc, K.S., Black, J.L., Yan, K., Armour, C.L., Donnelly, P.D. and Woolcock, A.J. (1983) Am. Rev. Respir. Dis. 128, 875– 879. Corradetti, R., Moneti, G., Moroni, F., Pepeu, G. & Wieraszko, A. (1983) J. Neurochem. 41, 1518– 1525. Satoh, M., Ishihara, K., Iwama, T., Takagy, H. (1986) Neurosci. Lett. 68, 216– 220. Schindler, U., Rush, D.K. & Fielding, S. (1984) Drug. Dev. Res. 4, 567– 576. Spignoli, G. & Pepeu, G. (1987) Pharmacol. Biochem. Behav. 27, 491– 495. Clark, C.R., Birchmore, B., Sharif, N.A., Hunter, J.C., Hill, R.G. & Hughes J. (1988) Br. J. Pharmac. 93, 618– 629. Lahti, R.A., Mickelson, M.M., McCall, J.M. & Von Voightlander, P.F. (1985) Eur. J. Pharmac. 109, 281– 284. Perkins, M.N. & Dray, A. (1986) Am. Soc. Neurosci. Abs. 12, 55. Aram, J.A. et al. (1988) J. Pharm. Exp. Ther. in press. Collingridge, G.L. et al. (1988) Neurology & Neurobiology in press. Fletcher, E.J. et al. (1988) Br. J. Pharmac. in press. Honore, T. et al. (1988) Science, 241, 701– 703. Boulton, C.L. & O'Shaughnessy, C.T. (1988) Br. J. Pharm. (in press). Harrison, N.L. & Simmonds, M.A. (1985) Br. J. Pharm. 84, 381– 391. Hoshi, T., Garber, S.S. & Aldrich, R.W. (1988) Science 240, 1652– 55. Davies, J. & Watkins, J.C. (1985) Brain Res., 327, 113– 120. Honoré, T. et al. (1987) Soc. Neurosci. Abstr. 13, 109.7. Kent, A.P. & Webster, R.A. (1986) Neuropharmacology 25, 1023– 1030. Bristow, D.R., Bowery, N.G. & Woodruff, G.W. (1986) Eur.J.Pharmac 126, 303– 307. Johnson, J.W. & Ascher, P. (1987) Nature 325, 529– 531. Monaghan, D.T. & Cotman, C.W. (1985) J.Neurosci 5, 2909– 2919. Ottersen, O.P., Storm-Mathisen, J. & Somogyi, P. (1988) Brain Res 450, 342– 353. Wilkin, G.P., Csillag, A., Balazs, R. et al (1981) Brain Res 216, 11– 33. Zarbin M.A., Wamsley J.K. & Kuhar, M.J. (1981) J. Neurosci 1, 532– 547. Carter C. et al (1988). J. Pharm. Exp. Ther. In press. Jackson A. and Sanger D.J. (1988). Psychopharmacology 96, 87– 92. Tricklebank M.D. et al (1987). Eur. J. Pharmacol. 141, 497– 501. Willetts J. et al (1986). Soc. Neurosci. Ab. 12, 909. Baba, A., Nishiuchi, Y., Uemura, A., Tatsuno, T. & Iwata, H. (1988) J. Neurochem. 51, 237– 242. Donaldson, J., Brown, A.M. & Hill, S.J. (1987) Biochem. Pharmac., 37, 715– 723. Carter, C.J. et al. (1988) J. Neurochem. 51, 462– 468. Herdon, H. et al. (1987) Eur. J. Pharmac. 138, 69– 76. Herdon, H. & Nahorski, S.R. N.S. Arch. Pharmac. (in press). Jhamandas, K. & Marien, M. (1987) Br. J. Pharmac. 90, 641– 650. Lodge, D. (1987) Trends Pharmac. Sci. 8, 243– 244. Clark, D., Hjorth, S. and Carlsson, A. (1985) J. Neural Trans. 62, 1– 52, 171–207. Cunningham, K. and Appel, J. (1986) J. Pharmacol. exp. Therap. 237, 369– 377. Gallagher G.J., Lavanchy P.G., Wilson J.M., Hieble J.P. and DeMarinis R.M. (1985) J. Med. Chem., 28: 1533– 1536. Eden R.J., Harvey C.A., Owen D.A.A. and Parker S.G. (1988) Br. J. Pharmac., 93: 128P. Leonard, M.N. et al (1987). Biochem. J. 248, 595– 602. Seeman, P. (1981). Pharmacol. Rev. 32, 229– 313. Sharp, T. et al (1987). Eur. J. Pharmac. 142, 198– 8. Stamford, J.A. et al (1987). Eur. J. Pharmac. 139, 363– 4. Stoof, J.C. & Verheijden, P.H.F.M. (1986). Eur. J. Pharmac. 129, 205– 6. O'Boyle K.M. & Waddington J.L. (1987) J.Neurochem. 48, 1039– 1042. O'Boyle K.M. & Waddington J.L. (1988a) Br.J.Pharmac. 93, 132P. O'Boyle K.M. & Waddington J.L. (1988b) Br.J.Pharmac. (in press). Rothman R.B. & Westfall T.C. (1982) Mol.Pharmac. 21, 538– 547. Sibley D.R. & Creese I. (1980) Eur.J.Pharmac. 131– 133. Bradbury, A.J. et al. (1984) Neuropharmacology 23, 1025– 1031. Costall, B. et al. (1980) Eur. J. Pharmac. 63, 347– 358. Yanagisawa M., Kuriyara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T., 1988, Nature 332, 411– 415. Antunes, E., De Nucci, G. & Vane, J.R. (1988) J. Physiol., in press. Salvati, P. & Whittle, B.J.R. (1981) Prostaglandins, 22, 141– 156. Wallace, J.L, Morris, G.P., Krausse, E.J. & Greaves, S.E. (1982) Can. J. Physiol. Pharmacol. 60, 1686– 1699. Yanagisawa, M., Kurihara, H., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K. & Masaki, T. (1988) Nature, 332, 411– 415. D'Orleans-Juste, P., Antunes, E., De Nucci, G. & Vane, J.R. (1988). Br. J. Pharmac., 95, P809. Finet, M., De Nucci, G., Willoughby, D. & Vane, J.R. (1988). This meeting. Schramm, M., Thomas, G., Towart, R. & Franckowiak, G. (1983). Nature 303, 535– 537. Vane, J.R. (1964). Br. J. Pharmac. Chemother. 23, 360– 373. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K. & Masaki, T. (1988). Nature 332, 411– 415. Yanagisawa, M., et al., 1988 Nature, 332, 411– 415. Carroll, M.A., Schwartzman, M., Capdevila, J., Falck, J.R. and McGiff, J.C. (1987) European J. Pharmacol. 138, 281– 283. Oliw, E.H. (1984) Biochim. et Biophys. Acta, 793, 408– 415. Godfraind, T. et al. (1986) Pharmacol. Rev., 38, 321– 416. Jones, C.R. et al., (1988) This meeting. Schoeffter, P. & Miller, R.C. (1986) Mol. Pharmacol., 30, 53– 57. Yanagisawa, M. et al. (1988) Nature, 332, 411– 415. Davenport, A.P. et al. (1988) in ‘Molecular Neuroanatomy’ F.W. Leeuwen et al. (eds.), Elsevier, Amsterdam, In Press. D'Orleans-Juste, P. et al. (1988) Br. J. Pharmac. in press. Gille, E. et al. (1985) Naunyn-Schmiedeberg's Arch. Pharmacol., 331, 60– 70. Hughes, A.D. et al. (1988) Br. J. Pharmac. in press.
Referência(s)